DIMERIX INVESTOR CALL & PRESENTATION

About Dimerix Dimerix is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs, with a core focus on developing new therapies to treat inflammatory causes of kidney and respiratory disease Advancing three Phase 3 clinical studies Patent protected products with commercial manufacturing established Dimerix Demonstrated clinical efficacy¹; drug well understood, with strong safety profile¹ Strong outlook with potential for significant value² upside 1 ASX releases: 12Jul17, 180ct17, 27Mar18, 29Jul20, 14Sep20, 27Oct20, 28Jan 21, 24Mar21, 03Jun21, 07Jun21, 19Jul21 3 2 See slides 8 and 13 for market potential

View entire presentation